Item 1. Financial Statements
ITEM
1. FINANCIAL STATEMENTS
Contents
Page
Condensed consolidated balance sheets as of September 30, 2022 and June 30, 2022 (unaudited)
2
Condensed consolidated statements of operations and comprehensive loss for the three months ended September 30, 2022 and 2021 (unaudited)
3
Condensed consolidated statements of cash flows for the three months ended September 30, 2022 and 2021 (unaudited)
4
Condensed consolidated statements of shareholders’ equity for the three months ended September 30, 2022 and 2021 (unaudited)
5
Notes to condensed consolidated financial statements (unaudited)
6
– 17
1
NioCorp Developments Ltd.
Condensed Consolidated Balance Sheets
(expressed in thousands of U.S. dollars, except share data)
(unaudited)
As
of
Note
September
30, 2022
June
30,
2022
As restated
(a)
ASSETS
Current
Cash
$
3,192
$
5,280
Prepaid
expenses and other
189
402
Total
current assets
3,381
5,682
Non-current
Deferred transaction
costs
5
2,609
-
Deposits
35
35
Investment
in equity securities
10
10
Right-of-use
assets
76
94
Land
and buildings, net
850
850
Mineral
interests
16,085
16,085
Total
assets
$
23,046
$
22,756
LIABILITIES
Current
Accounts
payable and accrued liabilities
6
$
3,670
$
817
Related
party loan
9
2,000
2,000
Convertible
debt
7
914
2,169
Operating
lease liability
11
86
82
Total
current liabilities
6,670
5,068
Non-current
Warrant
liability
3
964
-
Operating
lease liability
11
-
23
Total
liabilities
7,634
5,091
SHAREHOLDERS’
EQUITY
Common
shares, unlimited shares authorized; shares outstanding: 27,939,322 at September 30,
2022 and 27,667,060 at June 30, 2022 (b)
8
130,684
129,055
Accumulated
deficit
( 114,274
)
( 110,397
)
Accumulated
other comprehensive loss
( 998
)
( 993
)
Total
shareholders’ equity
15,412
17,665
Total
liabilities and equity
$
23,046
$
22,756
(a) Amounts
are restated. See Note 3 for more information.
(b) Amounts of shares outstanding are restated to give retroactive
effect to the Reverse Stock Split (as defined below). See Note 2d for more information.
The
accompanying notes are an integral part of these condensed consolidated financial statements.
2
NioCorp Developments Ltd.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(expressed in thousands of
U.S. dollars, except share and per share data) (unaudited)
For
the three months ended
September 30,
Note
2022
2021
As restated
(a)
Operating expenses
Employee
related costs
$
293
$
319
Professional
fees
164
90
Exploration
expenditures
10
1,288
621
Other
operating expenses
337
226
Total
operating expenses
2,082
1,256
Change
in fair value of warrant liability
( 257 )
-
Loss
on debt extinguishment
1,622
-
Foreign
exchange loss
173
225
Interest
expense
258
605
Other
(gain) loss on equity securities
( 1
)
2
Loss
before income taxes
3,877
2,088
Income
tax benefit
-
-
Net loss
4
$
3,877
$
2,088
Other comprehensive
loss:
Net
loss
$
3,877
$
2,088
Other
comprehensive loss (gain):
Reporting
currency translation
5
( 124
)
Total
comprehensive loss
$
3,882
$
1,964
Loss
per common share, basic and diluted (b)
$
0.14
$
0.08
Weighted
average common shares outstanding (b)
27,792,631
25,802,304
(a) Amounts
are restated. See Note 3 for more information.
(b) Amounts are restated to give effect to the Reverse Stock Split. See Note 2d for more information.
The
accompanying notes are an integral part of these condensed consolidated financial statements.
3
NioCorp
Developments Ltd.
Condensed
Consolidated Statements of Cash Flows
(expressed
in thousands of U.S. dollars) (unaudited)
For
the three months ended
September 30,
2022
2021
As
restated (a)
CASH
FLOWS FROM OPERATING ACTIVITIES
Net
loss for the period
$
( 3,877
)
$
( 2,088
)
Adjustments
to reconcile net loss to net cash used in operations:
Unrealized
(gain) loss on equity securities
( 1
)
2
Accretion
of convertible debt
194
551
Noncash
lease expense
( 2
)
( 1
)
Change
in fair value of warrant liability
( 257
)
-
Loss
on debt extinguishment
1,622
-
Depreciation
1
1
Foreign
exchange loss
177
288
( 2,143
)
( 1,247
)
Change
in working capital items:
Prepaid
expenses and other
209
( 270
)
Accounts
payable and accrued liabilities
196
( 92
)
Net
cash used in operating activities
( 1,738
)
( 1,609
)
CASH
FLOWS FROM INVESTING ACTIVITIES
Acquisition
of land and buildings
-
( 16
)
Net
cash used in financing activities
-
( 16
)
CASH
FLOWS FROM FINANCING ACTIVITIES
Proceeds
from issuance of common shares
-
664
Share
issue costs
( 21
)
-
Related
party debt repayments
-
( 318
)
Net
cash provided by financing activities
( 21
)
346
Exchange
rate effect on cash and cash equivalents
( 329
)
( 170
)
Change
in cash and cash equivalents during period
( 2,088
)
( 1,449
)
Cash
and cash equivalents, beginning of period
5,280
7,317
Cash
and cash equivalent, end of period
$
3,192
$
5,868
Supplemental
cash flow information:
Amounts
paid for interest
$
-
$
40
Amounts
paid for income taxes
-
-
Non-cash
financing transactions:
Conversions
of debt for common shares
$
1,650
$
1,350
Deferred
transaction costs, accrued but not paid
2,809
-
(a) Amounts
are restated. See Note 3 for more information.
The
accompanying notes are an integral part of these condensed consolidated financial statements.
4
NioCorp
Developments Ltd.
Condensed
Consolidated Statements of Shareholders’ Equity
(expressed
in thousands of U.S. dollars, except for Common Shares outstanding) (unaudited)
For
the three months ended September 30, 2022 and 2021
Common
Shares Outstanding (b)
Common
Shares
Accumulated
Deficit
Accumulated
Other Comprehensive Loss
Total
Balance,
June 30, 2021
25,637,993
$
113,882
$
( 99,510
)
$
( 1,159
)
$
13,213
Exercise
of warrants
87,175
543
-
-
543
Exercise
of options
28,270
121
-
-
121
Debt
conversions
158,398
1,350
-
-
1,350
Reporting
currency translation
-
-
-
124
124
Loss
for the period
-
-
( 2,088
)
-
( 2,088
)
Balance,
September 30, 2021
25,911,836
$
115,896
$
( 101,598
)
$
( 1,035
)
$
13,263
Balance,
June 30, 2022
27,667,060
$
129,055
$
( 110,397
)
$
( 993
)
$
17,665
Debt
conversions
272,262
1,650
-
-
1,650
Share
issuance costs
-
( 21
)
-
-
( 21
)
Reporting
currency translation
-
-
-
( 5
)
( 5
)
Loss
for the period, as restated (a)
-
-
( 3,877
)
-
( 3,877
)
Balance,
September 30, 2022, as restated (a)
27,939,322
$
130,684
$
( 114,274
)
$
( 998
)
$
15,412
(a) Amounts
are restated. See Note 3 for more information.
(b) Amounts are restated to give retroactive effect to the Reverse Stock Split. See Note 2d for more information.
The
accompanying notes are an integral part of these condensed consolidated financial statements.
5
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September 30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
1. DESCRIPTION
OF BUSINESS
NioCorp
Developments Ltd. (“NioCorp” or the “Company”) was incorporated on February 27, 1987, under the laws of
the Province of British Columbia and currently operates in one reportable operating segment consisting of exploration and development
of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property (the “Elk Creek Project”)
located in southeastern Nebraska.
These
consolidated financial statements have been prepared on a going concern basis that contemplates the realization of assets and
discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These financial
statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.
The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 4, these matters raised substantial doubt about the Company's
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing and maintaining continued support from its shareholders and creditors.
2. BASIS
OF PREPARATION
a)
Basis of Preparation
and Consolidation
The
accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted
accounting principles of the United States of America (“U.S. GAAP”) and the rules and regulations of the Securities
and Exchange Commission (“SEC”). The interim condensed consolidated financial statements include the consolidated
accounts of the Company and its wholly owned subsidiaries with all significant intercompany transactions eliminated. The accounting
policies followed in preparing these interim condensed consolidated financial statements are those used by the Company as set
out in the audited consolidated financial statements for the year ended June 30, 2022. Certain transactions include reference
to Canadian dollars (“C$”) where applicable.
In
the opinion of management, all adjustments considered necessary (including reclassifications and normal recurring adjustments)
for a fair statement of the financial position, results of operations, and cash flows at September 30, 2022, and for all periods
presented, have been included in these interim condensed consolidated financial statements. Certain information and footnote disclosures
normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted
pursuant to appropriate SEC rules and regulations. These interim condensed consolidated financial statements should be read in
conjunction with the audited consolidated financial statements for the year ended June 30, 2022. The interim results are not necessarily
indicative of results for the full year ending June 30, 2023, or future operating periods.
b)
Recent Accounting
Standards
Issued
and Adopted
In
August 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”)
No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts
in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”), which simplifies the accounting for convertible instruments.
ASU 2020-06 removes certain accounting models which separate the embedded conversion features from the host contract for convertible
instruments. Either a modified retrospective method of transition or a fully retrospective method of transition is permissible
for the adoption of this standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim
periods within those fiscal years. The Company adopted ASU 2020-06 on July 1, 2022, with no material effect on the Company’s
current financial position, results of operations or financial statement disclosures.
6
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September
30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
Issued
and Not Effective
From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company’s consolidated financial statements upon adoption.
c)
Use of Estimates
The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the financial statements, and the reported amounts of expenses during the reporting period. The Company regularly evaluates
estimates and assumptions related to the deferred income tax asset valuations, convertible debt valuations, and share-based compensation.
The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes
to be reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The
actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent
there are material differences between estimates and the actual results, future results of operations will be affected.
d)
Basic and Diluted
Earnings per Share
On March 17, 2023, the Company
effected a reverse stock split (the “Reverse Stock Split”) of its common shares, without par value (“Common Shares”),
on the basis of one (1) post-Reverse Stock Split Common Share for every ten (10) pre-Reverse Stock Split Common Shares issued and
outstanding, with any fractional shares resulting from the Reverse Stock Split rounded down to the nearest whole share. All references
to share and per share amounts (excluding authorized shares), as well as Option and Warrant (each as defined below) amounts and
exercise prices, in the condensed consolidated financial statements and accompanying notes have also been restated to give retroactive
effect to the Reverse Stock Split.
Basic
net loss per share is computed by dividing net loss by the weighted average number of the Company’s Common Shares
outstanding during the period. Diluted net loss per share is computed by dividing the net loss by the weighted-average number
of Common Share equivalents outstanding for the period determined using the treasury stock method or the if-converted method,
as applicable. For purposes of this calculation, options to purchase Common Shares (“Options”) and warrants to
purchase Common Shares (“Warrants”) are considered to be Common Share equivalents and are only included in the
calculation of diluted net loss per share when their effect is dilutive. The following shares
underlying Options, Warrants, and outstanding convertible debt were antidilutive due to a net loss in the periods
presented and, therefore, were excluded from the dilutive securities computation as indicated below.
For
the three months ended
September 30,
Excluded
potentially dilutive securities (1) :
2022
2021
Options
1,446,400
1,522,500
Warrants
1,851,625
1,347,011
Convertible debt
103,000
1,474,400
Total potential
dilutive securities
3,401,025
4,343,911
(1)
The
number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average
outstanding calculations as required if the securities were dilutive.
3. RESTATEMENT
On February 16, 2021, the Company
entered into a Convertible Security Funding Agreement (as amended by Amendment #1 to the Convertible Security Funding Agreement
dated December 2, 2021, the “CSFA”) with Lind Global Asset Management III, LLC (“Lind”), pursuant to which
the Company issued a convertible security to Lind (the “Lind III Convertible Security”). Pursuant to the CSFA, Lind
had certain consent and participation rights applicable in connection with the Transaction (as defined below) and the proposed
financing transactions with Yorkville Advisors Global, LP (“Yorkville”), each as described in Note 13. On September
25, 2022, the Company and Lind entered into a Waiver and Consent Agreement (the “Lind Consent”), which included the
following principal terms: (i) the consent of Lind to the Transaction and the proposed financing transactions with Yorkville,
7
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September
30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
including all actions taken by NioCorp as set out in the Business Combination Agreement to permit the completion
of the Transaction; (ii) the consent of Lind to NioCorp’s expected cross-listing to The Nasdaq Stock Market LLC (“Nasdaq”)
and the consolidation of the Common Shares in order to meet the minimum listing requirements thereof; (iii) the waiver of Lind
of its participation right for up to 15% of the total offering in the proposed standby equity purchase agreement between NioCorp
and Yorkville; and (iv) the waiver of Lind of certain restrictive covenants in the CSFA.
As
consideration for entering into the Lind Consent, Lind received, amongst other things: (i) the right to receive a payment of $ 500 ,
which would be reduced to $ 200 if the Transaction has not been consummated on or before April 30, 2023 (collectively, the “Consent
Payment”); (ii) an extension of its existing participation rights under the CSFA in future financings of NioCorp for a further
two-year period, subject to certain exceptions as well as an extension of such participation rights beyond the additional two-year
period if Yorkville or any affiliate is a party to any such applicable transaction; and (iii) the right to receive additional
Warrants (the “Contingent Consent Warrants”) if on the date that is 18 months following consummation of the Transaction,
the closing trading price of the Common Shares on the Toronto Stock Exchange (the “TSX”) or such other stock exchange
on which such shares may then be listed, is less than C$10.00, subject to adjustments. The
number of Contingent Consent Warrants to be issued, if any, is based on the Canadian dollar equivalent (based on the then current
Canadian to US dollar exchange rate as reported by Bloomberg, LP) of $5,000 divided by the five-day volume weighted average price
of the Common Shares on the date of issuance. Further, the number of Contingent Consent Warrants issued will be proportionately
adjusted based on the percentage of Warrants currently held by Lind that are exercised, if any, prior to the issuance of any Contingent
Consent Warrants. The Lind Consent was signed as an amendment to the existing CSFA.
The
Company originally accounted for both the Consent Payment and Contingent Consent Warrants as contingencies under Accounting Standards
Codification (“ASC”) Topic 450: Contingencies.
The
identification of the need for the restatement arose during the Company’s quarterly close for the quarter ended March 31,
2023. Pursuant to these procedures, the Audit Committee, in consultation with the Company’s management, determined that
the Lind Consent should have been evaluated under ASC 470 – Debt (“ASC 470”), which requires an evaluation of
the contract amendment under ASC 470 debt modification guidance.
The Company performed a comparison
of the discounted cash flows of the Lind III Convertible Security pursuant to the original CSFA and pursuant to the CSFA as amended
by the Lind Consent and determined that a debt extinguishment loss of $201 had occurred. Further, ASC 470 requires that the minimum
estimated Consent Payment of $200 also be included in the calculation of the gain or loss on debt extinguishment. The Company also
evaluated the Contingent Consent Warrant feature included in the Lind Consent and determined that the Contingent Consent Warrants
meet the criteria to be considered separate, freestanding instruments, should be accounted for as a liability under ASC Topic 480,
Distinguishing Liabilities from Equity (“ASC 480”), and should be booked at fair value on the date of the Lind Consent,
with subsequent changes in valuation recorded as a non-operating gain or loss in the statement of operations. The following table
summarizes the components of the initial loss on debt extinguishment:
8
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September
30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
Schedule
Of Extinguishment Of Debt
Amount
Minimum
Consent Payment at inception
$ 200
Loss on debt extinguishment
201
Initial fair value of Contingent Consent Warrants
1,221
Initial loss on debt extinguishment
$ 1,622
Changes in the fair value of the Contingent Consent Warrants are presented below:
Amount
Initial valuation, September 25, 2022
$ 1,221
Change in valuation
( 257 )
Valuation at September 30, 2022
$ 964
The Contingent Consent Warrants
are classified as a Level 3 financial instrument and were valued utilizing a Monte Carlo simulation pricing model, which calculates
multiple potential outcomes for future share prices based on historic volatility of the Common Shares to determine the probability
of issuance at 18 months following the applicable valuation date and to determine the value of the Contingent Consent Warrants. The following table discloses the primary inputs into the Monte Carlo model at each valuation date, and the probability of issuance
calculated by the model.
Key Valuation Input
September
25, 2022
September
30, 2022
Share price on valuation date
$ 7.82
$ 10.40
Volatility
62.4 %
63.4 %
Risk free rate
3.93 %
4.04 %
Probability of issuance
59.4 %
45.5 %
The loss on debt extinguishment
is presented as a non-operating expense in the Company’s condensed consolidated statements of operations and comprehensive
loss. This change in accounting also resulted in a decrease in the amount of accretion to be recognized over the remaining life
of the Lind III Convertible Security. Accretion expenses are disclosed as a part of interest expense, which is not included as
a component of operating costs.
This correction to the Company’s
condensed consolidated statements of operations and comprehensive loss also impacts the Company’s condensed consolidated
balance sheet, condensed consolidated statements of shareholders’ equity, and certain notes to the condensed consolidated
financial statements for the three months ended September 30, 2022 as illustrated in the tables below. This correction does not
impact the condensed consolidated statements of cash flows besides offsetting adjustments between net loss, accretion of convertible
debt, and loss on debt extinguishment within the cash flows from operating activities section.
Restatement Impacts to the Condensed Consolidated Balance Sheet (unaudited)
As
of September 30, 2022
As Previously Reported
Restatement Impacts
Restated
Deferred transaction costs
$ 2,809
$ ( 200 )
$ 2,609
Total assets
23,246
( 200 )
23,046
Convertible debt
755
159
914
Total current liabilities
6,511
159
6,670
Warrant liability
-
964
964
Total liabilities
6,511
1,123
7,634
Accumulated deficit
( 112,951 )
( 1,323 )
( 114,274 )
Total shareholders’ equity
16,735
( 1,323 )
15,412
Total liabilities and equity
23,246
( 200 )
23,046
9
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September
30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
Restatement Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited)
For
the Three Months Ended September 30, 2022
As Previously Reported
Restatement Impacts
Restated
Interest expense
$ 300
$ ( 42 )
$ 258
Loss on debt extinguishment
-
1,622
1,622
Change in fair value of warrant liability
-
( 257 )
( 257 )
Loss before income taxes
2,554
1,323
3,877
Net loss
2,554
1,323
3,877
Total comprehensive loss
2,559
1,323
3,882
Loss
per share
$ 0.09
$ 0.05
$ 0.14
Weighted average shares
outstanding
27,792,631
-
27,792,631
Restatement Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited)
For the Three Months Ended September 30, 2022
As Previously Reported
Restatement Impacts
Restated
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period
$ ( 2,554 )
$ ( 1,323 )
$ ( 3,877 )
Accretion of convertible debt
236
( 42 )
194
Loss on debt extinguishment
-
1,622
1,622
Change in fair value of warrant liability
-
( 257 )
( 257 )
Restatement
Impacts to the Condensed Consolidated Statement of Shareholders’ Equity (unaudited)
As
of September 30, 2022
Common
Shares
Accumulated
Deficit
Accumulated
Other
Comprehensive
Loss
Total
As
Previously Reported
Balance, June 30, 2022
$ 129,055
$ ( 110,397 )
$ ( 993 )
$ 17,665
Debt conversions
1,650
-
-
1,650
Share issuance costs
( 21 )
-
-
( 21 )
Reporting currency translation
-
-
( 5 )
( 5 )
Loss for the period
-
( 2,554 )
-
( 2,554 )
Balance, September 30, 2022
$ 130,684
$ ( 112,951 )
$ ( 998 )
$ 16,735
Restatement
Impacts
Balance, June 30, 2022
$ -
$ -
$ -
$ -
Loss for the period
-
( 1,323 )
-
( 1,323 )
Balance, September 30, 2022
$ -
$ ( 1,323 )
$ -
$ ( 1,323 )
As
Adjusted
Balance, June 30, 2022
$ 129,055
$ ( 110,397 )
$ ( 993 )
$ 17,665
Debt conversions
1,650
-
-
1,650
Share issuance costs
( 21 )
-
-
( 21 )
Reporting currency translation
-
-
( 5 )
( 5 )
Loss for the period, as restated
-
( 3,877 )
-
( 3,877 )
Balance, September 30, 2022, as restated
$ 130,684
$ ( 114,274 )
$ ( 998 )
$ 15,412
As
previously reported, the Company restated its consolidated balance sheets as of June 30, 2022 and 2021, and consolidated statements
of operations and comprehensive income, equity and cash flows for the years ended June 30, 2022 and 2021. In addition, the restatement impacted
the first, second and third quarters of our fiscal year ended June 30, 2022. The summarized restatement impacts for the comparable
interim period in fiscal year 2022 are presented below. The restatement corrects errors related to the accounting for
the unamortized deferred financing costs and debt discounts upon extinguishments of debt related to debt conversions.
10
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September
30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
Restatement Impacts to the Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited)
For
the Three Months Ended September 30, 2021
As Previously Reported
Restatement Impacts
Restated
Foreign exchange loss
$ 210
$ 15
$ 225
Interest expense
492
113
605
Loss before income taxes
1,960
128
2,088
Net loss
1,960
128
2,088
Reporting currency translation
( 109 )
( 15 )
( 124 )
Total comprehensive loss
1,851
113
1,964
Loss per share
$ 0.08
$ -
$ 0.08
Weighted average shares
outstanding
25,802,304
-
25,802,304
Restatement Impacts to the Condensed Consolidated Statement of Cash Flows (unaudited)
For
the Three Months Ended September 30, 2021
As Previously Reported
Restatement Impacts
Restated
CASH FLOWS FROM OPERATING ACTIVITIES
Total loss for the period
$ ( 1,960 )
$ ( 128 )
$ ( 2,088 )
Accretion of convertible debt
438
113
551
Foreign exchange loss
273
15
288
Restatement Impacts to the Condensed Consolidated Statement of Shareholders' Equity (unaudited)
For
the Three Months Ended September 30, 2021
As Previously Reported
Restatement Impacts
Restated
June 30, 2021 opening balance adjustments:
Deficit
$ ( 99,076 )
$ ( 434 )
$ ( 99,510 )
Accumulated other comprehensive loss
( 1,143 )
( 16 )
( 1,159 )
Total Shareholders’ equity
13,663
( 450 )
13,213
Activity adjustments:
Loss for the period
( 1,960 )
( 128 )
( 2,088 )
Reporting currency translation
109
15
124
September 30, 2021 ending balance adjustments:
Deficit
( 101,036 )
( 562 )
( 101,598 )
Accumulated other comprehensive loss
( 1,034 )
( 1 )
( 1,035 )
Total equity
13,826
( 563 )
13,263
4.
GOING CONCERN ISSUES
The
Company incurred a loss of $ 3,877 for the three months ended September 30, 2022 (2021 - $ 2,088 ) and had a working capital deficit
of $3,289 and an accumulated deficit of $ 114,274 as of September 30, 2022. As a development stage issuer, the Company has not
yet commenced its mining operations and accordingly does not generate any revenue. As of September 30, 2022, the Company had cash
of $ 3,192 which may not be sufficient to fund normal operations for the next twelve months without deferring payment on certain
liabilities or raising additional funds. In addition, the Company will be required to raise additional funds for construction
and commencement of operations. These factors raise substantial doubt about the Company's ability to continue as a going concern.
11
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September
30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
The
Company’s ability to continue operations and fund its expenditures, which have historically averaged approximately $ 1,265
per quarter over the preceding three-year period, is dependent on management’s ability to secure additional financing. Management
is actively pursuing additional sources of financing, and while it has been successful in doing so in the past, there can be no
assurance it will be able to do so in the future. Other than the proposed business combination and potential financing packages
discussed in Note 13, the Company did not have any further funding commitments or arrangements for additional financing as of
September 30, 2022. These consolidated financial statements do not give effect to any adjustments required to realize the Company’s
assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected
in the accompanying financial statements.
Since
March 2020, several measures have been implemented in the United States, Canada, and the rest of the world in response to the
increased impact from the novel coronavirus (“COVID-19”) pandemic and subsequent COVID-19 variants. In addition, recent
worldwide events have created general global economic uncertainty as well as uncertainty in capital markets, supply chain disruptions,
increased interest rates, and the potential for geographic recessions. We believe this could have an adverse impact on our ability
to obtain financing, development plans, results of operations, financial position, and cash flows during the current fiscal year.
The full extent to which these events and our precautionary measures may continue to impact our business will depend on future
developments, which continue to be highly uncertain and cannot be predicted at this time.
5.
DEFERRED TRANSACTION
COSTS
The
Company has deferred third-party costs, including legal fees, other professional and consulting fees, and due diligence fees,
incurred in connection with the proposed transaction discussed in Note 13. These costs are deferred until closing, at which time
a portion of the costs will be recorded against convertible debt to be entered into in connection with the proposed transaction,
with the remainder treated as a reduction to the value of Common Shares issued.
6. ACCOUNTS
PAYABLE AND ACCRUED LIABILITIES
Schedule
of account payable and accrued liabilities
As
of
Note
September
30,
2022
June
30,
2022
Accounts
payable, trade
$
2,904
$
115
Accounts
payable accruals
467
654
Consent
accrual
13
200
-
Interest
payable to related party
9
51
-
Other
accruals
48
48
Total accounts payable
and accrued liabilities
$
3,670
$
817
7. CONVERTIBLE
DEBT
Changes
in the Lind III Convertible Security are as follows:
Lind
III Convertible Security
(Restated)
Balance, June 30,
2022
$
2,169
Accretion expense
194
Fair value increase due to debt extinguishment
201
Conversions
( 1,650
)
Balance, September
30, 2022
$
914
12
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September
30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
Based
on the Company’s closing Common Share price of C$ 14.30 as of September 30, 2022, conversion of the remaining Lind III Convertible
Security undiscounted face value of $ 815 (including accrued interest) would require the issuance of approximately 103,000 Common
Shares. For each C$ 0.10 change in the fair value of one Common Share, the total Common Shares the Company would be obligated to
issue would change by approximately 800 shares.
8. COMMON
SHARES
a) Stock
Options
Schedule
of stock option
Number of Options
Weighted Average Exercise Price
Balance, June 30, 2022
1,446,400
C$
8.30
Granted
-
-
Exercised
-
-
Cancelled/expired
-
-
Balance, September 30, 2022
1,446,400
C$
8.30
The
following table summarizes information about Options outstanding at September 30, 2022:
Exercise
Price
Expiry
Date
Number
Outstanding
Aggregate
Intrinsic Value
Number
Exercisable
Aggregate
Intrinsic Value
C$
4.70
November
9, 2022
280,400
C$
2,692
280,400
C$
2,692
C$
8.40
September
18, 2023
105,000
619
105,000
619
C$
5.40
November
15, 2023
378,500
3,369
378,500
3,369
C$
7.50
December
14, 2023
182,500
1,241
182,500
1,241
C$
7.50
December
16, 2023
52,500
357
52,500
357
C$
13.60
December
17, 2024
397,500
278
397,500
278
C$
11.00
May
30, 2025
50,000
165
50,000
165
1,446,400
C$
8,721
1,446,400
C$
8,721
The
aggregate intrinsic value in the preceding table represents the total intrinsic value, based on the Company’s closing Common
Share price of C$ 14.30 as of September 30, 2022, that would have been received by the Option holders had all Option holders exercised
their Options as of that date. There were no in-the-money Options vested and exercisable as of September 30, 2022. As of September
30, 2022, there was $ 0 of unrecognized compensation cost related to unvested share-based compensation arrangements granted under
the Option plans.
b) Warrants
Schedule
of warrant transactions
Number
of Warrants
Weighted
Average Exercise Price
Balance,
June 30, 2022
1,851,624
C$
11.60
Granted
-
-
Exercised
-
-
Cancelled/expired
-
-
Balance,
September 30, 2022
1,851,624
C$
11.60
13
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September
30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
At
September 30, 2022, the Company had outstanding exercisable Warrants, as follows:
Number
Exercise
Price
Expiry
Date
50,000
C$
8.00
December
18, 2022
441,211
C$
16.30
May
10, 2023
504,613
C$
11.00
June
30, 2024
855,800
C$
9.70
February
19, 2025
1,851,624
9. RELATED
PARTY TRANSACTIONS AND BALANCES
Borrowings
under the non-revolving credit facility agreement (the “Smith Credit Facility”) with Mark Smith, Chief Executive Officer,
President, and Executive Chairman of NioCorp, bear interest at a rate of 10 % and drawdowns from the Smith Credit Facility are
subject to a 2.5 % establishment fee. Amounts outstanding under the Smith Credit Facility are secured by all of the Company’s
assets pursuant to a general security agreement. The Smith Credit Facility contains financial and non-financial covenants customary
for a facility of its size and nature. The maturity date for the Smith Credit Facility is June 30, 2023.
As
of September 30, 2022, the principal amount outstanding under the Smith Credit Facility was $ 2,000 and accounts payable and accrued
liabilities as of September 30, 2022, include accrued interest of $ 51 payable under the Smith Credit Facility.
10. EXPLORATION
EXPENDITURES
Schedule
of exploration expenditures
For
the Three Months Ended September 30,
2022
2021
Technical
studies and engineering
$
141
$
50
Field
management and other
154
124
Metallurgical
development
993
436
Geologists
and field staff
-
11
Total
$
1,288
$
621
11.
LEASES
The
Company incurred lease costs as follows:
For
the Three Months Ended September 30,
2022
2021
Operating
Lease Cost:
Fixed
rent expense
$
21
$
21
Variable
rent expense
3
2
Short
term lease cost
2
5
Sublease
income
( 6
)
( 5
)
Net
lease cost – other operating expense
20
23
14
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September
30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
The
maturities of lease liabilities are as follows at September 30, 2022:
Fiscal
Year Lease Maturities
Total
lease payments – through September 2023
$
93
Less
portion of payments representing interest
( 7
)
Present
value of lease payments – current lease liability
$
86
12. FAIR
VALUE MEASUREMENTS
The
Company measures the fair value of financial assets and liabilities based on U.S. GAAP guidance which defines fair value, establishes
a framework for measuring fair value, and expands disclosures about fair value measurements.
The
Company classifies financial assets and liabilities as held-for-trading, available-for-sale, held-to-maturity, loans and receivables,
or other financial liabilities depending on their nature. Financial assets and financial liabilities are recognized at fair value
on their initial recognition.
Financial
assets and liabilities classified as held-for-trading are measured at fair value, with gains and losses recognized in net income.
Financial assets classified as held-to-maturity, loans and receivables, and financial liabilities other than those classified
as held-for-trading are measured at amortized cost, using the effective interest method of amortization. Financial assets classified
as available-for-sale, including investments in equity securities, are measured at fair value, with unrealized gains and losses
being recognized in income.
Financial
instruments including receivables, accounts payable and accrued liabilities, and related party loans are carried at amortized
cost, which management believes approximates fair value due to the short-term nature of these instruments.
The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of September 30, 2022, and June 30, 2022, respectively, and indicate the fair value hierarchy of the valuation techniques the
Company utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted)
in active markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable,
such as quoted prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points
for the financial instrument and include situations where there is little, if any, market activity for the instrument.
Schedule
of fair values determined by level 3 inputs are unobservable data
As
of September 30, 2022
Total
Level
1
Level
2
Level
3
Assets:
Cash and
cash equivalents
$
3,192
$
3,192
$
-
$
-
Equity
securities
10
10
-
-
Total
$
3,202
$
3,202
$
-
$
-
Liabilities:
Warrant
Liability
$
964
$
-
$
-
$
964
As
of June 30, 2022
Total
Level
1
Level
2
Level
3
Assets:
Cash and
cash equivalents
$
5,280
$
5,280
$
-
$
-
Equity
securities
10
10
-
-
Total
$
5,290
$
5,290
$
-
$
-
15
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September
30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
The
Lind III Convertible Security discussed in Note 7 was initially recorded at fair value, which represented a nonrecurring fair
value measurement using a Level 3 input. At September 30, 2022, the estimated fair value of this instrument approximated carrying
value given that the instrument was adjusted to fair value on September 25, 2022 and has a short remaining life until maturity.
13. PROPOSED
TRANSACTION
On
September 25, 2022, the Company, GX Acquisition Corp. II, a Delaware corporation (“GXII”), and Big Red Merger Sub
Ltd (“Merger Sub”), a Delaware corporation incorporated in September 2022, and a direct, wholly owned subsidiary of
the Company, entered into a business combination agreement (the “Business Combination Agreement”). Pursuant to the
Business Combination Agreement, as the result of a series of transactions, GXII will become a subsidiary of the Company (as successor
by merger to the Company’s subsidiary, Elk Creek Resources Corporation, a Delaware corporation (“ECRC”)), with
the pre-combination public shareholders of GXII receiving Common Shares based on a fixed exchange ratio of 1.11829212 (the “Exchange
Ratio”) Common Shares for each GXII Class A common share held and not redeemed, and the GXII founders receiving shares in
GXII (as successor by merger to ECRC) based on the Exchange Ratio. Pursuant to the Business Combination Agreement, after closing,
the GXII founders will have the right to exchange such shares for Common Shares on a one-for-one basis under certain conditions.
Pursuant to the Business Combination Agreement, the Company will also assume the obligations under the issued and outstanding
GXII warrants, which will be converted into warrants exercisable into Common Shares following closing of the Transaction. The
Business Combination Agreement contemplates that the Company will undertake a reverse stock split of the Common Shares at the
time of close in connection with an expected cross-listing to the Nasdaq Stock Market (“Nasdaq”). In addition, pursuant
to the Business Combination Agreement, post-closing, the Company’s Board will include two directors from pre-combination
GXII. The transactions contemplated by the Business Combination Agreement and the ancillary agreements thereto are referred to
collectively as the “Transaction.”
As
currently structured, the Business Combination Agreement is expected to be accounted for as a recapitalization in accordance with
U.S. GAAP. Under this method of accounting, GXII will be treated as the “acquired” company for financial reporting
purposes. Accordingly, the transaction is treated as the equivalent of NioCorp issuing Common Shares for the net assets of GXII,
accompanied by a recapitalization. The net assets of GXII will be stated at historical cost, with no goodwill or other intangible
assets recorded.
In
addition, in connection with the entry into the Business Combination Agreement, the Company announced the signing of non-binding
letters of intent (“LOIs”) for two separate financing packages with Yorkville. Subject to entering into definitive
agreements, these financings could provide the Company with access to up to an additional $ 81 .0 million to help advance the Elk
Creek Project. The financings contemplated by the LOIs include $ 16 .0 million in convertible debentures that are expected to be
funded at the closing of the Transaction, and subject to certain limitations can be repaid by the Company in either cash or Common
Shares, and a standby equity purchase facility pursuant to which the Company will have the ability to require Yorkville, subject
to the conditions set out in the definitive agreements, to purchase up to $ 65 .0 million of its Common Shares.
The
proposed Transaction is expected to close in the first calendar quarter of 2023, subject to the satisfaction or waiver of certain
customary closing conditions contained in the Business Combination Agreement, including, among other things, (i) obtaining required
approvals of the Transaction and related matters by the respective shareholders of NioCorp and GXII, (ii) the effectiveness of
the registration statement on Form S-4 that the Company originally filed on November 7, 2022, (iii) receipt of approval for listing
on Nasdaq of the NioCorp Common Shares to be issued in connection with the Transaction, (iv) receipt of approval for listing on
Nasdaq of the NioCorp warrants to be issued in exchange for the GXII warrants that NioCorp has agreed to assume, (v) receipt of
approval from the TSX with respect to the issuance and listing of the NioCorp Common Shares issuable in connection with the Transaction,
(vi) that NioCorp and its subsidiaries (including GXII, as successor by merger to ECRC) will have at least $ 5.000001 million of
net tangible assets upon the consummation of the Transaction, after giving effect to any redemptions by GXII public stockholders
and after payment of underwriters’ fees or commissions, (vii) that, at closing, NioCorp and its subsidiaries (including
GXII, as successor by merger to ECRC) will have received cash in an amount equal to or greater than $ 15.0 million ,
16
NioCorp
Developments Ltd.
Notes
to the Condensed Consolidated Financial Statements
September
30, 2022
(expressed
in thousands of U.S. dollars, except per share amounts or as otherwise stated) (unaudited)
subject to
certain adjustments, and (viii) the absence of any injunctions enjoining or prohibiting the consummation of the Business Combination
Agreement. The proposed additional financings contemplated by the LOIs will also be subject to the approval of the TSX and the
Company’s shareholders.
17
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.